Fool.com contributor Parkev Tatevosian evaluates GSK(NYSE: GSK) and its longer-term prospects to determine if it's a fantastic stock to buy for dividend stock investors.
*Stock prices used were the afternoon prices of Aug. 12, 2023. The video was published on Aug. 14, 2023.
10 stocks we like better than GSK
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and GSK wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of August 14, 2023
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends GSK. The Motley Fool has a disclosure policy.
Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
